Aqumeldi

Aqumeldi is used in children and adolescents from birth to 17 years of age to treat heart failure (when the heart is not able to pump enough blood around the body). Aqumeldi contains the active substance enalapril and is a ‘hybrid medicine’. This means that it is similar to an authorised reference medicine containing the same active substance, but there are certain differences between the two. Aqumeldi is available at a lower dose than its reference medicine, Renitec, and in a different form that is appropriate for children.